From Chemical to Drug: The Path to Small Molecule IND [event recap]

On Wednesday, March 6th, the Pennovation Center hosted the JPOD @ Philadelphia panel, “From Chemical to Drug: Path to a Small Molecule IND,” which discussed filing Investigational New Drug (IND) applications. This session brought Janssen experts from across the drug development landscape to Pennovation: Michael Kelley, Senior Scientific Director, Nonclinical Safety, Janssen R&D; Dolly A. Parasrampuria, BPharm, MPhil, PhD, Scientific Director, Clinical Pharmacology & Pharmacometrics, Janssen R&D; Mark Krook, Global Head, SM CMC Leadership – Small Molecule Pharmaceutical Development; and Alla Rhoge, Global Regulatory Affairs - Immunology, Janssen R&D. The 20 participants learned about formulation considerations, the FDA process, issues of scale, and even some “medicinal chemistry 101”! The panel fielded questions across wide-ranging fields and sciences; their expertise offered something for everyone.